Citing "unacceptable levels" of toxins in the products, the WHO is seeking information about the raw materials used by six manufacturers in India and Indonesia
The government has begun inspecting some drug factories across the country, the health ministry said on Tuesday, as it tries to ensure high standards after an Indian company's cough and cold syrups were linked to deaths in Gambia.
The select committee of the West African nation's National Assembly submitted its report on December 20 saying the Gambian regulator had relied on a fitness certificate provided by Maiden Pharmaceuticals but the cough syrup maker flouted good manufacturing practices.